Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 14,941 | 20,645 | 16,022 | 11,603 | 12,359 |
| Cost of Goods | 10,527 | 16,480 | 11,287 | 7,400 | 7,475 |
| Gross Profit | 4,414 | 4,165 | 4,735 | 4,203 | 4,884 |
| Operating Expenses | 20,743 | 15,435 | 18,985 | 19,334 | 22,626 |
| Operating Income | -15,802 | -10,790 | -13,963 | -14,731 | -17,267 |
| Interest Expense | 797 | 788 | 771 | 1,009 | 755 |
| Other Income | 112 | 175 | 230 | 323 | 110 |
| Pre-tax Income | -16,487 | -11,403 | -14,504 | -15,417 | -17,912 |
| Income Tax | 34 | 20 | 32 | -9 | 77 |
| Net Income Continuous | -16,521 | -11,423 | -14,536 | -15,408 | -17,989 |
| Net Income | $-16,521 | $-11,423 | $-14,536 | $-15,408 | $-17,989 |
| EPS Basic Total Ops | -0.30 | -0.21 | -0.26 | -0.28 | -0.37 |
| EPS Basic Continuous Ops | -0.30 | -0.21 | -0.26 | -0.28 | -0.37 |
| EPS Diluted Total Ops | -0.30 | -0.21 | -0.26 | -0.28 | -0.37 |
| EPS Diluted Continuous Ops | -0.30 | -0.21 | -0.26 | -0.28 | -0.37 |
| EBITDA(a) | $-13,778 | $-8,802 | $-12,259 | $-13,002 | $-15,677 |